Less is more: level IB-sparing radiation therapy in nasopharyngeal cancer
Radiation Oncology Journal. 2023;41(1):1-3 
Level Ib sparing intensity-modulated radiation therapy in selected nasopharyngeal carcinoma patients based on the International Guideline
Radiotherapy and Oncology. 2022;167:239-243
Results of a Phase 2 Study Examining the Effects of Omitting Elective Neck Irradiation to Nodal Level IB in Nasopharyngeal Carcinoma Patients With Negative Level IB Lymph Nodes Treated With Intensity Modulated Radiation Therapy
International Journal of Radiation Oncology*Biology*Physics. 2014;90(1):S178
Less is more: role of additional chemotherapy to concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal cancer management
Radiation Oncology Journal. 2019;37(2):67-72
Feasibility and safety of neck level IB-sparing radiotherapy in nasopharyngeal cancer: a long-term single institution analysis
Radiation Oncology Journal. 2022;40(4):260-269
The risk of level IB nodal involvement in oropharynx cancer: Guidance for submandibular gland sparing irradiation
Practical Radiation Oncology. 2017;7(5):e317-e321
Sparing level Ib lymph nodes by intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma
International Journal of Clinical Oncology. 2013;19(6):998-1004
The Feasibility of Selectively Omission of Radiation to Level IB Lymph Nodes in Low-Risk Nasopharyngeal Carcinoma
International Journal of Radiation Oncology*Biology*Physics. 2017;99(2):S238
Radiation therapy and chemotherapy in early and advanced nasopharyngeal cancer
An Evidence-Based Approach to the Management of Nasopharyngeal Cancer. 2020;189-227
Salvage Radiation Therapy for Locally Recurrent Nasopharyngeal Cancer
Nasopharyngeal Cancer. 2021;103-112